drugset / Trial / NCT00469417

Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma

NCT00469417

Phase 3 Completed 120 enrolled Galderma R&D
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to compare the efficacy of Photodynamic Therapy (PDT) methyl aminolevulinate (MAL) cream to cryotherapy, in treatment of participants with primary superficial basal cell carcinoma (BCC). Secondary objectives was to compare cosmetic outcome and tolerability (adverse events) in these participants, 3 months after treatment. In addition the recurrence rates in the two treatment groups will be compared up to five years after treatment.

Timeline

Start
1999-10-18
Primary completion
2001-09-05
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject methyl aminolevulinate Small molecule 160 unknown Topical